Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04088760
What this trial is testing

TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati 15
Large-scale testing (Phase 3)Looking for participantsNCT07583888
What this trial is testing

VABu Conditioning in Elderly AML HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 20
Large-scale testing (Phase 3)Ended earlyNCT00616954
What this trial is testing

Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

Who this might be right for
Allogeneic Haplo-Stem Cell Transplatation (SCT)Graft Versus Host Disease
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)UnknownNCT05599256
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT00942305
What this trial is testing

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Infection
Jazz Pharmaceuticals 239
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT03359980
What this trial is testing

Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer

Who this might be right for
Fecal Microbiota Transplantation
MaaT Pharma 24
Not applicableLooking for participantsNCT07688759
What this trial is testing

CMV-CMI in csCMVi After HSCT

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)Immune Reconstitution
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Study completedNCT01814488
What this trial is testing

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

Who this might be right for
Acute Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 101
Testing effectiveness (Phase 2)UnknownNCT06075927
What this trial is testing

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Who this might be right for
CMV InfectionEBV InfectionStem Cell Transplant
Peking University People's Hospital 29
Not applicableUnknownNCT05078073
What this trial is testing

HBOT in the Treatment and Prevention of aGVHD

Who this might be right for
Hyperbaric Oxygen TherapyAcute-graft-versus-host Disease
Shandong Provincial Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06613035
What this trial is testing

Twice-per-weekSelinexor, 2 Days Melphalan

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 126
Post-approval studies (Phase 4)UnknownNCT03190733
What this trial is testing

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Who this might be right for
Chronic Graft-versus-host-diseaseLeukemia Relapse
Zhujiang Hospital 192
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04451200
What this trial is testing

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Who this might be right for
Acute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm
Institut Paoli-Calmettes 82
Next Page